Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ANNOUNCEMENT OF THE NAV OF P CAPITAL PARTNERS III

Press release Stockholm, 29 July 2022 Since P Capital Partners III decreased its contributed capital by SEK 287.9 million through a repayment to debenture holders and owners, the Net Asset Value of the P Capital Partners III participation loan has been calculated. The Net Asset Value is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The repayment amounted to SEK 25,000 per Series A participation loan debenture, SEK 625,000 per Series B participation loan debenture and SEK 31.8 million to the owners. At the close of business

Atlas Copco has acquired a compressor distributor in Georgia, USA

Nacka, Sweden, July 29, 2022: Atlas Copco has acquired the operating assets of Compressed Air Products, Inc. (CAP). CAP sells to a broad range of industrial customer segments. It also has a strong service business.CAP is located in Newnan, Georgia, south-west of Atlanta, and has 20 employees. “CAP has a strong reputation in the Georgia market,” said Vagner Rego, Business Area President Compressor Technique. “We have a long relationship with CAP as a distributor. This acquisition is in line with our strategy to get closer to our customers.” The purchase price is not disclosed. The

Paratus Energy Services Ltd Announces Trading Update for First Quarter 2022 and Other Updates

Hamilton, Bermuda, July 29, 2022 - Paratus Energy Services Ltd. (“Paratus” or the “Company”) today announced a trading update for the first quarter 2022 and updates on Paratus, its subsidiaries, and associated companies (“Paratus Group”). 1. Key Financial Highlights 1.1    Paratus In the first quarter ending March 31, 2022, Paratus generated $54 million in revenue and $29 million in EBITDA[1]. As a result of the pre-packaged Chapter 11 restructuring on January 20, 2022, comparisons of revenue and EBITDA to the preceding quarter are not meaningful. 1.2    SeaMex Group During

HALF YEAR REPORT, SECOND QUARTER 2022

  Press release: Stockholm, July 29, 2022, 08.45 CET HIGHLIGHTS OF THE SECOND QUARTER 2022 · Net sales was 90 MSEK compared to the previous year 109 MSEK. Decrease was due to declined silver price and lower production · EBITDA was 6 MSEK (36) · EBIT was -16 MSEK (16) · Cash and cash equivalents were 43 MSEK (52) · Investments were 24 MSEK (5) · The production was about 281 000 (382 000) ounces of silver, 796 (988) ounces of gold, 365 (396) tonnes of lead, and 824 (919) tonnes of zinc in concentrates · New mining contract was signed with Veljekset

SOTKAMO SILVER AB: UPDATED GUIDANCE FOR SILVER PRODUCTION IN 2022

Press release: Stockholm, July 29, 2022, 08:45 CET Sotkamo Silver AB revises the estimate for silver production in 2022. The updated guidance is based on the silver production of 617 koz until the end of the second quarter, and updated production schedule for the second half of the year. The production volumes of gold, zinc and lead have been at the same level or exceeded the volumes during the same period last year. New production guidance for 2022: We continue to focus on the production mix and optimization of the revenue and operative cashflow. Consequently, we estimate that our

Idogen is preparing to start the clinical phase 1/2a study with IDO 8 in Norway

Idogen AB (publ) is working intensively on the preparations for the company's first clinical study with the cell therapy IDO 8 in patients with severe hemophilia A and is meeting a great deal of commitment at participating study centers. In Norway, the company's clinical trial center has come a long way in preparations for the study.   Idogen has previously received approval from both the Swedish and the Norwegian Medicines Agency to start the study, and in Norway, patients who are suitable for inclusion have now been identified. Professor Pål Andre Holme, senior physician at Oslo

Sleep Cycle interim report April-June 2022 - Stable growth and strong operating margin

The positive development from the start of the year continued in the second quarter. Net sales increased by 19.0%, equivalent to an increase of 16.1% adjusted for currency effects. The operating margin increased to 24.4% thanks to effective cost control and growth in revenue. The total number of users increased but was impacted by seasonal variations and price adjustments. As anticipated, new user acquisition was only partially affected by the price adjustments, resulting in an overall higher sales value.Second quarter summary (April-June 2022) · Net sales increased by 19.0% (12.5)%

BioStock: Norwegian doctors prepare for Idogen’s study

Biotech company Idogen is in full swing with preparations for the first clinical study with the cell therapy IDO 8 in patients with severe haemophilia A. BioStock had the opportunity to interview Professor Pål André Holme, Chief Physician at Oslo University Hospital and Clinical Investigator in Idogen’s study, and Dag Josefsen, who is Chief Physician and Head of Department at the Section of Cell Therapy.Read the full article at biostock.se: https://www.biostock.se/en/2022/07/norwegian-doctors-prepare-for-idogens-study/ This is a press release from BioStock - Connecting Innovation &

Chair succession

29 July 2022 07:01 BST Michel Demaré to succeed Leif Johansson as Non-Executive Chair of the Board AstraZeneca PLC today announced the appointment of Michel Demaré as the Chair-designate of the Board. His appointment followed a robust succession planning process led by Philip Broadley in his capacity as senior independent Non-Executive Director. As previously communicated, Leif Johansson, current Chair of the Board of AstraZeneca will be retiring at the conclusion of the Company's Annual General Meeting in April 2023.  Michel's appointment will take effect immediately on Leif'

Axolot Solutions Holding AB (publ) - Interim report January-June 2022

Successful trials at Aspa Bruk, letter of intent signed regarding the Norwegian market and oversubscribed preferential rights issue completed.Summary of the second quarter 2022 Financially · Net sales amounted to 350 tSEK (529 tSEK for the corresponding quarter in 2021), which refers to customer trial activities and studies. · Other revenues were 0 tSEK (60), where the revenue in the comparison period relates to public research grants and project support. · Earnings before interest and tax became -5 108 tSEK (-4 954), that is relatively unchanged. · Net earnings per share

Number of shares and votes in Oncopeptides

Stockholm, Sweden — July 29, 2022 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announces that the number of shares and votes in Oncopeptides has changed as a result of the company’s share issue as announced on July 14, 2022. As a result of the share issue, the number of outstanding shares and votes has increased by 15,061,443 from 75,307,217 to 90,368,660. The share capital has increased by approximately SEK 1,673,494 from SEK 8,367,469 to SEK 10,040,963.For further

SkartaNYAB Oyj - Managers' Transactions

SkartaNYAB PlcMANAGERS' TRANSACTIONS29 July 2022 at 09:00SkartaNYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: BINGAB Barents Investment Group ABPosition: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In IssuerName: Johan LarssonPosition: Chief Executive Officer Issuer: SkartaNYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 18114/5/6____________________________________________

Conversion of shares in Skanska AB

According to Skanska AB’s articles of association, holders of Series A shares are entitled to submit requests to the company for conversion of their shares to Series B shares. Such conversion reduces the total number of votes in the company.In conjunction with a conversion of shares, the company is obliged according to the Swedish Financial Instruments Trading Act (1991:980) to disclose information concerning the change. During July 2022, 931 Series A shares were converted to Series B shares at the request of shareholders. Accordingly, the total number of votes in the company thereafter

Tokmanni Group Corporation Half-Year Financial Report January–June 2022: Revenue at the previous year’s level, EBIT burdened by cost increases

Tokmanni Group Corporation        Half-Year Financial Report        29 July 2022 at 8.30 a.m.SECOND QUARTER 2022 HIGHLIGHTS · Revenue grew by 1.7 % (5.4%) and was EUR 306.7 million (301.5) · Like-for-like revenue for stores decreased by 1.5% (+4.4%) · Comparable gross profit totalled EUR 106.9 million (105.8), with the comparable gross margin being 34.8% (35.1%) · Comparable EBIT amounted to EUR 27.0 million (32.3), representing 8.8% of revenue (10.7%) · Cash flow from operating activities amounted to EUR 62.8 million (61.5) · Earnings per share, diluted was EUR 0.35 (0.

A strong quarter throughout the Group - EBITDA increased by 29 percent

SECOND QUARTER APRIL–JUNE · The Group’s net sales amounted to SEK 284.1 (233.4) million, an increase of 22 percent. · The Group’s EBITDA was SEK 59.4 (46.1) million, an increase of 29 percent. · The EBITDA margin was 21 (20) percent. · Profit after tax amounted to SEK 21.1 (16.4) million. · Earnings per share amounted to SEK 1.4 (1.1). · Cash flow from operating activities was SEK 24.4 (33.1) million. HALF-YEAR JANUARY–JUNE · The Group’s net sales amounted to SEK 546.9 (456.0) million, an increase of 20 percent. · The Group’s EBITDA was SEK 115.6 (86.6)

Nordea Bank Abp: Repurchase of own shares on 28.07.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares28.07.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 28.07.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XHEL 31,590 9.48 299,590.08CEUX 28,166 9.49 267,376.74TQEX 3,251 9.50 30,871.59XSTO 32,908 9.50 312,692.83XCSE 4,

Key information relating to cash dividend to be paid by Otello Corporation ASA

The Board of Otello Corporation ASA (OSE: OTEC) has resolved to pay a dividend payment of NOK 21 per share, NOK 1 913 094 309 in total.  The dividend is resolved pursuant to the Authorization granted by the Annual General Meeting held on 2 June 2022. Otello Corporation ASA's cash position as of today is approximately 2 090 million NOK. Key information relating to the cash dividend: Issuer: Otello Corporation ASA Dividend amount: 21 NOK per share and 1 913 094 309 NOK in total Announced currency: NOK Last day including right: 8 August 2022 Ex-date: 9 August 2022

Martin Larsson moves his ownership in K-Fastigheter to a Swedish endowment insurance

Martin Larsson, deputy CEO and CFO of K-Fast Holding AB (publ), will during June 29th, through his fully owned company Martin Larsson Holding AB move his ownership in K-Fastigheter to a Swedish endowment insurance. This will be reported in the PDMR transactions register at Finansinspektionen (the Swedish Financial Supervisory Authority). The transfer is only internally in Martin Larsson Holding AB whereby Martin Larssons ownership in K-Fastigheter remain the same. For more information, please contact:Martin Larsson, deputy CEO and CFOe-post: martin.larsson@k-fastigheter.se, telephone:

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 28.07.2022

Fiskars Corporation   Stock Exchange Release 28.07.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 28.07.2022   Date 28.07.2022  Exchange transaction Buy  Share class FSKRS  Amount  4,800  Average price/share 18.9645 EURHighest price/share 19.1400 EURLowest price/share 18.3600 EURTotal price 91,029.60 EUR        The shares held by Fiskars Corporation on 28.07.2022:   FSKRS 899,837       On

#22-260 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#22-259 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

There are no items matching the current filter
There are no more items matching the current filter
Back to top